Form D · Pharmaceuticals
Biofrontera Inc.
Woburn, MA · CIK 0001858685
Offering snapshot reported Jul 11, 2025 · SEC filing
- Reported sold
- $11M Offering amount: $11M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2025 | Initial | $11,000,000 | No comparison | 5 | SEC filing |
| Dec 5, 2024 | Initial | $4,200,000 | No comparison | 5 | SEC filing |
| Mar 5, 2024 | Initial | $8,000,000 | No comparison | 8 | SEC filing |
| Nov 4, 2022 | Initial | $3,683,209 | No comparison | 1 | SEC filing |
| Aug 11, 2022 | Initial | $7,114,287 | No comparison | 1 | SEC filing |
| May 23, 2022 | Initial | $9,400,681 | No comparison | 1 | SEC filing |
| Dec 10, 2021 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551526
The issuer agreed to sell up to 11,000 shares of its Series C Convertible Preferred Stock & issue such shares in two tranches of 8,500 shares & 2,500 shares, respectively, as disclosed in a Current Report on Form 8-K filed with the SEC on July 1, 2025.
Series C Convertible Preferred Stock
Source: Form D, filed Jul 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John J Iii Borer | Director |
| John J. Borer Iii | Director |
| Erica F Gates | Executive |
| Beth J. Hoffman | Director |
| Heikki Lanckriet | Director |
| Eugene Frederick Leffler | Executive |
| Eugene Frederick Leffler, Iii | Executive |
| Hermann Luebbert | Director, Executive |
| Erica L Monaco | Executive |
| Kevin D. Weber | Director |
| Loretta M Wedge | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
120 Presidential Way, Suite 330
Woburn, MA, 01801
Phone: 781-245-1325
Woburn, MA, 01801
Phone: 781-245-1325